top of page

Ureteral Cancer

Ureteral Cancer

Ureteral cancer, also known as ureter cancer, is a rare type of cancer that originates in the ureters. The ureters are thin, muscular tubes that carry urine from the kidneys to the bladder. Ureteral cancer occurs when abnormal cells in the lining of the ureters start to grow uncontrollably, forming a tumor.
Ureteral cancer is relatively uncommon, and it typically affects adults, with a higher incidence in people over the age of 65.

What is ureteral cancer

What is ureteral cancer?

Risk factors

The development of ureteral cancer can be influenced by various risk factors. While the presence of these risk factors doesn't guarantee that an individual will develop the disease, they can increase the likelihood. Common risk factors associated with ureteral cancer include:

  1. Age: Ureteral cancer is more common in adults, particularly in individuals over the age of 65.

  2. Gender: Ureteral cancer is slightly more common in men than in women.

  3. Smoking: Smoking is a significant risk factor for ureteral cancer. The harmful chemicals in tobacco smoke can be absorbed into the bloodstream and excreted in the urine, potentially leading to damage in the ureters' lining.

  4. Exposure to Industrial Chemicals: Occupational exposure to certain industrial chemicals, such as aromatic amines and aniline dyes, is linked to an increased risk of ureteral cancer. People working in certain industries, like chemical manufacturing, may be at higher risk.

  5. Chronic Irritation or Infection: Long-term irritation or inflammation of the ureters, often due to factors like recurrent urinary tract infections, kidney stones, or the use of urinary catheters, may increase the risk of ureteral cancer.

  6. Bladder Cancer History: Individuals with a history of bladder cancer are at a slightly increased risk of developing ureteral cancer.

  7. Genetic Factors: Some rare genetic conditions, such as hereditary nonpolyposis colorectal cancer (HNPCC) or Lynch syndrome, are associated with an elevated risk of ureteral cancer.

It's important to note that the exact cause of ureteral cancer is not always clear, and many cases occur in individuals without any known risk factors. Reducing certain modifiable risk factors, such as quitting smoking, minimizing exposure to industrial carcinogens, and managing urinary tract infections, can help reduce the risk of ureteral cancer. Additionally, maintaining regular medical check-ups and being vigilant about any unusual symptoms, such as blood in the urine or unexplained pain, can aid in the early detection and timely management of ureteral cancer if it does develop.

Risk factors of Ureteral Cancer


Ureteral cancer can initially develop without noticeable symptoms, and when symptoms do appear, they may be vague and resemble those of other urinary tract or kidney-related conditions. However, it's crucial to be aware of potential symptoms and seek medical evaluation if you experience any of the following:

  1. Hematuria: Blood in the urine (hematuria) is the most common and often the first noticeable symptom of ureteral cancer. Hematuria can make the urine appear pink, red, or brown. It may be intermittent and not always visible to the naked eye.

  2. Flank or Abdominal Pain: Some individuals with ureteral cancer may experience pain in the lower back, side (flank), or abdomen. This pain can be persistent and may worsen over time.

  3. Frequent Urination: An increased need to urinate, often accompanied by a sense of urgency, can be a symptom of ureteral cancer.

  4. Painful Urination: Discomfort or a burning sensation during urination can occur.

  5. Urinary Tract Infections: Recurrent urinary tract infections (UTIs) may be a sign of ureteral cancer, as tumors can obstruct the flow of urine and promote infection.

  6. Unexplained Weight Loss: While not specific to ureteral cancer, unexplained weight loss can sometimes be a symptom, especially in advanced stages of the disease.

  7. Swelling of the Lower Extremities: In rare cases, ureteral cancer may obstruct the flow of urine, leading to swelling (edema) in the legs or feet.

It's important to recognize that these symptoms can also be related to various other, non-cancerous conditions, such as urinary tract infections, kidney stones, or other kidney disorders. Nevertheless, if you experience any of these symptoms, particularly if they persist or worsen, it is essential to consult a healthcare professional for a proper evaluation.
Early detection and diagnosis of ureteral cancer can lead to more effective treatment and better outcomes. If you are at higher risk due to factors like smoking, exposure to industrial chemicals, or a history of urinary tract infections, it is advisable to maintain regular check-ups and be vigilant about any unusual symptoms.

Symptoms of Ureteral Cancer

The diagnosis of ureteral cancer typically involves a series of medical evaluations, tests, and procedures to confirm the presence of cancer, determine its stage, and guide treatment decisions. Here is an overview of the diagnostic process for ureteral cancer:

  1. Medical History and Physical Examination:

    • Your healthcare provider will begin by taking a detailed medical history, including questions about your symptoms, risk factors, and family history.

    • A physical examination may be conducted to assess your general health and identify any signs that may suggest ureteral cancer.

  2. Urine Analysis (Urinalysis):

    • A urinalysis is often one of the first diagnostic tests performed. It can detect the presence of blood in the urine (hematuria) and may also identify other urinary abnormalities.

  3. Imaging Studies:

    • Imaging tests, such as ultrasound, computed tomography (CT) scans, magnetic resonance imaging (MRI), and intravenous pyelogram (IVP), may be used to create detailed images of the urinary tract. These tests can help identify the presence of tumors in the ureters and assess their size and location.

  4. Cystoscopy:

    • Cystoscopy is a procedure that involves inserting a thin, flexible tube with a camera (cystoscope) through the urethra and into the bladder. This allows the healthcare provider to visualize the inside of the bladder and, in some cases, the lower ureters to look for abnormalities. A biopsy may also be taken during cystoscopy if a tumor is identified.

  5. Ureteroscopy:

    • For a more detailed evaluation of the ureters, ureteroscopy may be performed. This procedure involves using a thin, flexible tube with a camera (ureteroscope) to visualize the ureters and potentially collect tissue samples (biopsies) for laboratory analysis.

  6. Biopsy:

    • Tissue samples collected during cystoscopy or ureteroscopy may be sent to a laboratory for histological examination. A biopsy can confirm the presence of cancer and provide information on the type and grade of the cancer.

  7. Staging:

    • If ureteral cancer is confirmed, it is staged to determine the extent of the disease. Staging helps to assess whether the cancer is localized to the ureter or has spread to other organs or lymph nodes.

  8. Additional Tests:

    • Depending on the stage and grade of the cancer, additional tests, such as chest X-rays, bone scans, or other imaging studies, may be conducted to evaluate whether the cancer has spread to other parts of the body.

Once the diagnosis and staging are complete, a healthcare team can work with the patient to develop a personalized treatment plan tailored to the specific characteristics of the cancer and the patient's overall health. Treatment options for ureteral cancer may include surgery, chemotherapy, radiation therapy, and targeted therapies, among others. The choice of treatment is based on individual circumstances and preferences. Regular follow-up care is important to monitor for recurrence and manage any potential side effects or complications.


Diagnosis of Ureteral Cancer

The treatment of ureteral cancer depends on several factors, including the stage and grade of the cancer, the location of the tumor, the patient's overall health, and individual preferences. Treatment options for ureteral cancer may include:

  1. Surgery:

    • Surgical removal of the tumor is often the primary treatment for ureteral cancer. The specific surgical approach depends on the tumor's location and extent.

    • For tumors that are limited to the lower ureter, segmental ureterectomy may be performed to remove the affected portion of the ureter.

    • For tumors in the upper ureter, radical nephroureterectomy is often recommended, which involves the removal of the entire affected kidney, the ureter, and a portion of the bladder.

    • Minimally invasive techniques, such as laparoscopic or robot-assisted surgery, may be used when feasible.

  2. Chemotherapy:

    • Chemotherapy, which uses drugs to kill or slow the growth of cancer cells, may be used in several ways for ureteral cancer treatment:

      • Neoadjuvant chemotherapy: Administered before surgery to shrink the tumor and make it easier to remove.

      • Adjuvant chemotherapy: Given after surgery to reduce the risk of cancer recurrence.

      • Systemic chemotherapy: Used for advanced or metastatic ureteral cancer.

  3. Radiation Therapy:

    • Radiation therapy uses high-energy X-rays to target and destroy cancer cells. It may be used in combination with surgery or as part of a palliative treatment plan for advanced cases.

  4. Immunotherapy:

    • Some patients with advanced ureteral cancer may be candidates for immunotherapy, which stimulates the immune system to recognize and attack cancer cells. Immune checkpoint inhibitors are among the immunotherapeutic agents used in the treatment of certain cancers.

  5. Targeted Therapy:

    • Targeted therapy drugs are designed to interfere with specific molecules involved in the growth of cancer cells. Some targeted therapies may be used in clinical trials or for advanced ureteral cancer cases.

  6. Clinical Trials:

    • Clinical trials may be available for individuals with ureteral cancer. These trials investigate new treatments, therapies, or approaches and can provide access to cutting-edge therapies.

The choice of treatment depends on the specific characteristics of the cancer, including its stage, grade, and whether it has spread beyond the ureter, as well as the patient's age, overall health, and personal preferences. Treatment plans are typically discussed with a multidisciplinary team of healthcare providers, which may include urologists, medical oncologists, radiation oncologists, and other specialists. Regular follow-up care is important to monitor for recurrence and manage any potential side effects or complications.


Treatment of Ureteral Cancer

bottom of page